Mark Erlander
Chief Executive Officer presso CARDIFF ONCOLOGY, INC.
Patrimonio netto: 43 209 $ in data 29/02/2024
Profilo
Currently, Mark Erlander occupies the position of Chief Executive Officer & Director at Cardiff Oncology, Inc.
Dr. Erlander previously held the position of Chief Scientific Officer at Gensignia Life Sciences, Inc., Chief Scientific Officer of Arcturus Studios Holdings, Inc., Principal at Johnson & Johnson, Chief Scientific Officer for Biotheranostics, Inc. and Assistant Professor at The Scripps Research Institute.
He received a doctorate from the University of California, Los Angeles, a graduate degree from Iowa State University and an undergraduate degree from the University of California, Davis.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
CARDIFF ONCOLOGY, INC.
0.05% | 07/03/2024 | 24 481 ( 0.05% ) | 43 209 $ | 29/02/2024 |
Posizioni attive di Mark Erlander
Società | Posizione | Inizio |
---|---|---|
CARDIFF ONCOLOGY, INC. | Chief Executive Officer | 08/05/2020 |
Precedenti posizioni note di Mark Erlander
Società | Posizione | Fine |
---|---|---|
Gensignia Life Sciences, Inc.
Gensignia Life Sciences, Inc. BiotechnologyHealth Technology Gensignia Life Sciences, Inc. is a molecular diagnostics company that develops new molecular diagnosis techniques. The private company is based in San Diego, CA. The company was founded by Gabriele Marco Antonio Cerrone. | Chief Tech/Sci/R&D Officer | 01/03/2014 |
Biotheranostics, Inc.
Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 01/02/2013 |
Arcturus Studios Holdings, Inc.
Arcturus Studios Holdings, Inc. Packaged SoftwareTechnology Services Arcturus Studios Holdings, Inc. specializes in editing and compressing volumetric video through their holostream and holosuite products. Arcturus Studios Holdings is based in Beverly Hills, CA and has subsidiaries in Canada. These products provide adaptive streaming volumetric video for uninterrupted experiences delivered on demand. The company has received positive feedback from clients such as Crescent Studios, Far East Company, Inc., and NTT Docomo, Inc. for their professional-grade tools and ability to anticipate customer needs. Holoedit and holosuite have been used in various projects, including those featuring BTS and the 2019 Samsung Developer Conference. The company was founded by Devin Horsman, Andy Stack, and Ewan Johnson, and the CEO is Kamal Mistry. | Chief Tech/Sci/R&D Officer | 01/01/2008 |
JOHNSON & JOHNSON | Corporate Officer/Principal | 01/01/2000 |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | Corporate Officer/Principal | 01/01/1994 |
Formazione di Mark Erlander
University of California, Los Angeles | Doctorate Degree |
Iowa State University | Graduate Degree |
University of California, Davis | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
JOHNSON & JOHNSON | Health Technology |
CARDIFF ONCOLOGY, INC. | Health Technology |
Aziende private | 3 |
---|---|
Biotheranostics, Inc.
Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Health Services |
Gensignia Life Sciences, Inc.
Gensignia Life Sciences, Inc. BiotechnologyHealth Technology Gensignia Life Sciences, Inc. is a molecular diagnostics company that develops new molecular diagnosis techniques. The private company is based in San Diego, CA. The company was founded by Gabriele Marco Antonio Cerrone. | Health Technology |
Arcturus Studios Holdings, Inc.
Arcturus Studios Holdings, Inc. Packaged SoftwareTechnology Services Arcturus Studios Holdings, Inc. specializes in editing and compressing volumetric video through their holostream and holosuite products. Arcturus Studios Holdings is based in Beverly Hills, CA and has subsidiaries in Canada. These products provide adaptive streaming volumetric video for uninterrupted experiences delivered on demand. The company has received positive feedback from clients such as Crescent Studios, Far East Company, Inc., and NTT Docomo, Inc. for their professional-grade tools and ability to anticipate customer needs. Holoedit and holosuite have been used in various projects, including those featuring BTS and the 2019 Samsung Developer Conference. The company was founded by Devin Horsman, Andy Stack, and Ewan Johnson, and the CEO is Kamal Mistry. | Technology Services |